Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase NA 2Phase 1 2Phase EARLY_PHASE1 1Phase 4 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Classical hematology 1

Conditions

Sarcoma 1

Interventions

Imatinib Mesylate 3nilotinib 2Sunitinib 2Ibandronic Acid 2Doxorubicin 2Cyclophosphamide 2regorafenib 1pegylated granulocyte colony-stimulating factor 1nirogacestat 1avapritinib 1anlotinib 1Zoledronic Acid 1Tranexamic Acid 1Thiotepa 1Ritonavir 1Radiotherapy 1Pregabalin 1Oxaliplatin 1Nevirapine 1Midazolam 1Lopinavir 1Lithium Carbonate 1Lead 1Kyphoplasty 1Indocyanine Green 1Ifosfamide 1Hyperbaric Oxygenation 1Filgrastim 1Esomeprazole 1Erlotinib Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Brachytherapy × Sarcoma × Clear all
NCT04033081 2026-03-23

Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®

CivaTech Oncology

Phase 4 Active not recruiting
100 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡